logo

Blogs Forms State Regulations Client Login
  • About E&I
    • Company Profile
    • Scope of Studies
    • Our Boards
    • Contact Us
    • Services
      • Fees
        • Multi Site Fees
        • Single Site Fees
      • Translation Services
      • Contracting with Us
    • Our Compliance Policy
  • Investigators / Sites
    • About Investigator Section
    • Initial Submissions
      • Joining a Multi-site Study
      • Submitting Single-site Studies
      • Submitting Investigator Initiated Studies
      • Other Review Categories
      • Individual/Emergency/HUD
      • Biological Specimens
    • Post Approval Reporting Obligations
      • Modifications/Changes in Research
      • Reporting Violations/Problems
      • New Information
    • Continuing Review
    • Recruitment / Advertising
    • Closing a Study
    • Investigator Training
  • Sponsor / CRO
    • About Sponsor Section
    • Initial Sponsor Submission
      • Multi-site Studies
    • Protocol Amendments and Revisions
    • Reporting Obligations/Agreements
      • Unanticipated Problems
      • New Information
    • Continuing Review
    • Closing a Study
    • Extra
  • Research Participants
    • About Participant Section
    • Frequently Asked Questions
    • Links
  • Training and Consulting
  • Search
Home

Guidance

  • IRB Review
    • Is IRB Review Required?
    • Types of Review Available
    • IRB Review Exemption
    • More on Expedited Review
    • Protocol Design Issues
    • Non-Local Issues
    • Risk Analysis
    • Multi-center Studies
  • Subject Protection
    • Defining an HRPP
    • E&I's HRPP
    • E&I's Conflict of Interest Policy
    • E&I's Compliance Policy / Registration
    • E&I's PI / Site Training Requirements
    • Basics of HRPP Development
  • Program & Responsibility
    • FWA Basics
    • FWA Policy Overview
    • FWA Sample SOP
  • Informed Consent (IC)
    • IC Overview
    • IC Process
    • E&I's HIPAA Policy
  • Biological Specimens
    • Points to Consider
    • Consent Template
  • Device Studies
    • Device Basics
    • NSR vs SR
    • E&I NSR Policy
    • Risk Evaluation Tool
  • Humanitarian Devices
    • Humanitarian Devices Basics
    • HUD Part 812.100
  • Non-Invasive Research
    • Clinical Effectiveness Research (CER)
    • Outcomes Research
    • Qualitative Research

Regulatory Guidance

  • FDA Guidance
  • OHRP Guidance
  • Belmont Report
  • Your IRB Should Speak the Same...

Resources

  • FDA News
  • Industry News
  • Pharmaceuticals News

 

Two experienced companies, one shared commitment.

 

In 2010 Independent Review Consulting (IRC) merged with

the Ethical Review Committee (ERC) to form

Ethical and Independent Review Services (E&I).

 

With over 45 years of combined experience, E&I provides

prompt, high quality reviews of research

on behalf of subject safety.

         ERCLogo   IRC Logoaahrppseal

 
Ethical and Independent Review Services © 2010